PharmaShots | Incisive News in 3 Shots

Subscribe Now

89bio

89bio Commences P-III Study of Pegozafermin for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)

89bio Commences P-III Study of Pegozafermin for Treating Metabolic Dysfunction-Associated Steatohepatitis (MASH)

March 13, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us